Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Carenzo
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
ORCID:
0000-0001-6804-9984
Observed ORCID:
0000-0001-6804-9984
OpenAlex ID:
A5016357939
Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma
2019
·
Laura D. Locati
, Mara S. Serafini
, et al.
·
Cancers
·
48
PDF
hacksig: a unified and tidy R framework to easily compute gene expression signature scores
2022
·
Andrea Carenzo
, Federico Pistore
, et al.
·
Bioinformatics
·
29
PDF
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma
2019
·
Patrizia Gasparini
, Orazio Fortunato
, et al.
·
Cancers
·
29
PDF
Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples
2022
·
Emanuela Minna
, Paola Romeo
, et al.
·
Cancers
·
28
PDF
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma
2021
·
Stefano Cavalieri
, Mara S. Serafini
, et al.
·
JCO Precision Oncology
·
24
PDF
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
2020
·
Caterina Peraldo-Neia
, Paola Ostano
, et al.
·
Cellular Oncology
·
24
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions
2020
·
Andrea Carenzo
, Mara S. Serafini
, et al.
·
Cells
·
23
PDF
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
2020
·
Salvatore Alfieri
, Andrea Carenzo
, et al.
·
Cancers
·
20
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
·
Clinical Cancer Research
·
16
PDF
A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy
2022
·
Maria F. Iannó
, Veronica Biassoni
, et al.
·
Cancers
·
14
PDF
Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages
2021
·
Andrea Ferrari
, Maria Federica Iannó
, et al.
·
Pediatric Blood & Cancer
·
12
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials
2022
·
Deborah Lenoci
, Andrea Carenzo
, et al.
·
Oral Oncology
·
8
Gene expression-based dissection of inter-histotypes, intra-histotype and intra-tumor heterogeneity in pediatric tumors
2022
·
Sara Ciceri
, Andrea Carenzo
, et al.
·
Scientific Reports
·
7
PDF
DIPG-36. The brain-gut-microbiota axis to predict outcome in pediatric diffuse intrinsic pontine glioma
2022
·
Loris De Cecco
, Veronica Biassoni
, et al.
·
Neuro-Oncology
·
6
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report
2022
·
Laura Deborah Locati
, Mara Serena Serafini
, et al.
·
Frontiers in Oncology
·
6
PDF
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
2022
·
Stefano Cavalieri
, Mara Serena Serafini
, et al.
·
Cells
·
3
PDF
hacksig: A Tidy Framework to Hack Gene Expression Signatures
2021
·
Andrea Carenzo
, Loris De Cecco
, et al.
·
2
Table 3 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
·
1
Figure 1 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
Data from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
Supplementary Figure S1 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
Table 1 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
Supplementary Table S3 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
Figure 3 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
Supplementary Table S2 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)
2025
·
Dario Callegaro
, Gabriele Tinè
, et al.
Show more works
View as search
Works count:
33
Citation count:
300
H-index:
11
I10-index:
11
Year
Topic
Type